Delivery Order SPE2DB22D1041-SPE2DB25FTZH1

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,397.71, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides for the delivery of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a prescription medication. This delivery order contract has a firm fixed price pricing type and an ultimate completion date of September 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This award is a delivery order under contract SPE2DX15D6044, issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,476.05 firm-fixed-price order is for the delivery of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a prescription medication. The order has an ultimate completion date of August 13, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a specialty pharmaceutical product, with a potential value of $11,268.17. This delivery order falls under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp that has a potential value of $999,999,999.00 and a performance period through December 31, 2025....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a specialty medication. The total ceiling value of the contract is $4,449.55, with a completion date of January 28, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,867.91, is for the delivery of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a medication used to treat migraines. The contract has an ultimate completion date of January 8, 2025 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $1,476.05 firm fixed-price contract is for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a specialty medication, to support military treatment facilities and federal healthcare programs. This award is not associated with a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,832.46 firm fixed-price delivery order is for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a medication used to treat migraine headaches. The award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of the pharmaceutical product Imitrex 6 mg/0.5 ml pen injector, with a ceiling value of $1,510.23 and a performance period through May 8, 2024. This order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00...
This is a federal delivery order contract awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a prescription medication, at a ceiling value of $1,180.88. The contract has a firm fixed price pricing type and a period of performance ending on May 22, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $3,713.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a specialty medication, with a completion date of December 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB25FTZH1
    Delivery Order

This is a Delivery Order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a medication used to treat migraines. The award has a ceiling value of $11,510.83 and a period of performance through January 29, 2025. This award is issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current award does not have a set-aside designation, indicating open competition.

Generated 4/29/25, 9:52 AM